Evidence map›Paper›PMID 35915069›Full record

ArticleCell discovery2022

Single-cell analysis reveals differences among iNKT cells colonizing peripheral organs and identifies Klf2 as a key gene for iNKT emigration.

Jie Wang, Ian Loveless, Indra Adrianto, Tingting Liu, Kalpana Subedi, Xiaojun Wu, Md Moazzem Hossain, Eric Sebzda, Li Zhou, Qing-Sheng Mi

Open access · goldAbstract read
In one paragraph

Article in Cell discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. KLF2 is a clinical diagnostic and treatment biomarker of breast cancer.Frontiers in cell and developmental biology · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jie Wang *Center for Cutaneous Biology and Immunology, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
Ian Loveless *Center for Cutaneous Biology and Immunology, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
Indra Adrianto *Center for Cutaneous Biology and Immunology, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.ORCID http://orcid.org/0000-0002-9973-3057
Tingting LiuCenter for Cutaneous Biology and Immunology, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
Kalpana SubediCenter for Cutaneous Biology and Immunology, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
Xiaojun WuCenter for Cutaneous Biology and Immunology, Department of Dermatology, Henry Ford Health, Detroit, MI, USA.
Md Moazzem HossainDepartment of Biochemistry, Microbiology, and Immunology, Wayne State University School of Medicine, Detroit, MI, USA.
Eric SebzdaDepartment of Biochemistry, Microbiology, and Immunology, Wayne State University School of Medicine, Detroit, MI, USA.
Li ZhouCenter for Cutaneous Biology and Immunology, Department of Dermatology, Henry Ford Health, Detroit, MI, USA. lzhou1@hfhs.org.
Qing-Sheng MiCenter for Cutaneous Biology and Immunology, Department of Dermatology, Henry Ford Health, Detroit, MI, USA. QMI1@hfhs.org.ORCID http://orcid.org/0000-0002-1411-6827
Henry Ford Health System · USWayne State University · US

Funding

microRNAs and NKT cell development and functionR01AI119041 · NIAID · HENRY FORD HEALTH SYSTEM · PI MI, QING-SHENG · 2016 to 2020
$1.8M
Uncover the new subsets of epidermal Langerhans cellsR61AR076803 · NIAMS · HENRY FORD HEALTH SYSTEM · PI ADRIANTO, INDRA, MI, QING-SHENG · 2019 to 2020
$746k
microRNAs and NKT cell development and functionR56AI119041 · NIAID · HENRY FORD HEALTH SYSTEM · PI MI, QING-SHENG · 2015 to 2015
$371k
Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) 1R56AI119041-01Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) 1R61AR076803-01Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) AI119041-01A1Henry Ford Health System T71016Henry Ford Health System T71017NIAID NIH HHS R01 AI119041NIAID NIH HHS R56 AI119041NIAMS NIH HHS R61 AR076803
6 · The paper itself

Abstract

Invariant natural killer T cell (iNKT) subsets are differentially distributed in various immune organs. However, it remains unclear whether iNKT cells exhibit phenotypical and functional differences in different peripheral organs and how thymic iNKT cells emigrate to peripheral organs. Here, we used single-cell RNA-seq to map iNKT cells from peripheral organs. iNKT1 cells from liver, spleen, and lymph node appear to have distinct phenotypic profiles and functional capabilities. However, iNKT17 transcriptomes were comparable across peripheral organs. In addition, by integrating data with a thymic iNKT cell study, we uncovered a transient population of recent thymic emigrants, a cluster of peripheral iNKT cells with high expression of transcription factor Kruppel-like factor 2 (Klf2). Deletion of Klf2 led to a severe impairment of iNKT differentiation and migration. Our study revealed that iNKT subsets are uniquely distributed in peripheral organs with some inter-local tissue variation, especially for iNKT1 cell, and identified Klf2 as a rheostat for iNKT cell migration and differentiation.

Identifiers

PMID35915069
PMCPMC9343440
OpenAlexW4289519587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.